API Regulatory Affairs in Pharmaceutical Industry
Under our API vertical, we research, develop and provide various essential products that are used by pharma companies across the world to make key medicines that are essential for humankind. Through our innovation-oriented and research-led approach, we are focusing on generic product development. Furthermore, our team work effortlessly to ensure cost effective commercialisation of our products. Presently, we have commercialised various APIs and several new APIs are in the advanced stage of development.
Our Products
● = Available for reference |
● = Granted |
● = Ready |
● = Filed |
● = Registered |
● = Available
Learn About Ibuprofen & its derivatives
Learn About our new products
| Products | Therapeutic Category | CAS No. | Std. Batch Size(kg) | USDMF | KFDA | CEP | MOH Russia | EUWC | WHO GMP | DMF/ Tech Pack | Click Below |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ibuprofen | NSAID | 15687-27-1 | 1000 | Learn More | |||||||
| Ibuprofen Lysinate | NSAID | 57469-76-8 | 600* | - | - | - | - | Learn More | |||
| Ibuprofen Sodium | NSAID | 31121-93-4 | 800* | - | - | - | - | - | Learn More | ||
| Dex-Ibuprofen | NSAID | 51146-56-6 | 200* | - | - | - | - | - | - | Learn More | |
| Metformin HCL | Anti-Diabetic | 1115-70-4 | 1500 | Learn More | |||||||
| Clopidogrel Bisulphate (Form II) | Anti-Platelet | 120202-66-6 | 550 | Learn More | |||||||
| Pantoprazole Sodium | Proton Pump Inhibitor | 164579-32-2 | 500 | Learn More | |||||||
| Fenofibrate (Micronised) | Anti-Cholesterol | 49562-28-9 | 550 | Learn More | |||||||
| Paracetamol | Anti-Convulsant | 60142-96-3 | 700 | - | Learn More | ||||||
| Lamotrigine | Anti-Convulsant | 84057-84-1 | 165* | Learn More | |||||||
| Losartan Potassium | Anti-Hypertensive | 124750-99-8 | 400 | - | - | Learn More | |||||
| Levetiracetam | Anti-Epileptic | 102767-28-2 | 250* | - | Learn More | ||||||
| Paracetamol | Analgesic & Antipyretic | 103-90-2 | 1500 | - | - | Learn More |
| Product Name | Therapeutic Category | CAS No. | Under Development | Under Validation |
|---|---|---|---|---|
| Quetiapine Fumarate | Anti-Psychotic | 111974-72-2 | Completed | Completed |
| Allopurinol | Xanthine Oxidase | 315-3-0 | Completed | Completed |
| Irbesartan | Anti-Hypertensive | 138402-11-6 | Completed |
 |
| Valsartan | Anti-Hypertensive | 137862-53-4 | Completed |
|
| Vildagliptin | Anti-Diabetic | 274901-16-5 | Completed |
|
| Sitagliptin M Phosphate | Anti-Diabetic | 654671-77-9 | Completed |
|
| Minoxidil | Anti-Hypertensive | 38304-91-5 |
|
- |
| Mesalazine | Anti-Inflammatory | 89-57-6 |
|
- |
| Ketoconazole | Azole Antifungals | 65277-42-1 |
|
- |
| Sacubitril | Neprilysin Inhibitor | 149709-62-6 |
|
- |
| Edoxaban | Oral Anticoagulant | 480449-70-5 |
|
- |
| Product Name | CAS No. | API |
|---|---|---|
| (S)-Methyl 2-(2-chlorophenyl)-2-((thiophen-2-yl)ethyl)amino acetate hydrochloride (Coupled amine hydrochloride) | 141109-19-5 | Clopidogrel |
| 2-(2,3-Dichlorophenyl)-2-guanyliminoacetonitrile (Schiff's Base) | 84689-20-3 | Lamotrigine |
| 2,4-Diamino-6-hydroxypyrimidine (KSM) | 56-06-4 | Minoxidil |
| 2,4-Diamino-6-chloropyrimidine (2,4-DACP) | 156-83-2 | Minoxidil |
| 2,4-Diamino-6-chloropyrimidine 3-N-Oxide | 35139-67-4 | Minoxidil |
